Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.81 CAD | +2.42% | +2.14% | -29.05% |
May. 02 | Eupraxia Pharmaceuticals Forms Gastrointestinal Clinical Advisory Board | MT |
Apr. 08 | Top Premarket Decliners | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 133M 96.97M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.3% |
1 day | +0.81% | ||
1 week | -4.62% | ||
Current month | +0.81% | ||
1 month | -5.58% | ||
3 months | -37.79% | ||
6 months | -29.81% | ||
Current year | -30.73% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 12-07-22 | |
Bruce G. Cousins
DFI | Director of Finance/CFO | 63 | 21-05-02 |
Amanda Malone
CTO | Chief Tech/Sci/R&D Officer | - | 12-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Geyer
BRD | Director/Board Member | 61 | 13-01-13 |
John Montalbano
FOU | Founder | 59 | 11-12-31 |
Richard Glickman
BRD | Director/Board Member | 65 | 21-03-08 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 3.81 | +2.42% | 7 000 |
24-05-02 | 3.72 | +0.81% | 15,300 |
24-05-01 | 3.69 | 0.00% | 6,160 |
24-04-30 | 3.69 | +0.27% | 15,250 |
24-04-29 | 3.68 | -1.34% | 22,422 |
Delayed Quote Toronto S.E., May 02, 2024 at 03:59 pm EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.73% | 96.7M | |
+26.28% | 48.09B | |
-3.99% | 40.43B | |
+46.73% | 40.62B | |
-6.20% | 28.36B | |
+6.36% | 24.89B | |
-21.47% | 19.01B | |
+27.58% | 12.09B | |
-2.75% | 11.8B | |
-2.02% | 11.88B |
- Stock Market
- Equities
- EPRX Stock